Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,447 total articles
Upexi, Inc., a Nasdaq-listed company specializing in Solana-based digital asset treasury and consumer brands, announced a private placement raising approximately $19.5 million by issuing over 12 million shares at about $1.60 each. The proceeds are used to reduce existing debt. The offering was made without a placement agent and complies with securi…
Castor Maritime Inc., a NASDAQ-listed diversified global shipping and energy company, announced the agreement to acquire a modern 2023-built eco-friendly Kamsarmax bulk carrier for $37.5 million. The vessel acquisition, expected to close by the end of the quarter, will expand the company's fleet to 10 vessels, enhancing its dry bulk shipping capaci…
BridgeBio Pharma announced that positive primary results from its Phase 3 PROPEL 3 trial of oral infigratinib in children with achondroplasia will be presented at the International Congress of Children's Bone Health (ICCBH) 2026. The company will also share additional research findings on quality of life, early intervention, and disease monitoring …
BrainsWay Ltd., a leader in advanced noninvasive brain stimulation technologies, announced significant expansion in favorable medical coverage across the U.S. for its SWIFT Accelerated Deep TMS protocol. Eight major payers and the US Department of Veterans Affairs now cover or support this treatment, impacting over 57 million covered lives. The cov…
Medicus Pharma Ltd., a Nasdaq-listed biotech company, announced its participation in the 2026 Bio International Conference to present advancements in its clinical development programs for SkinJect®, an innovative treatment for basal cell carcinoma and Gorlin Syndrome, and Teverelix®, a next-generation GnRH antagonist targeting prostate cancer, acut…
Streamex Corp. (NASDAQ: STEX) announced the May 2026 yield dividend distribution for GLDY, its gold-backed yield-bearing tokenized security. The distribution covers the period from May 1 to May 31, 2026, with GLDY holders receiving 0.002884 GLDY per token, representing an annualized yield of 3.5% generated via Streamex's institutional gold leasing …
Palvella Therapeutics announced that the FDA has granted rolling review for its New Drug Application (NDA) for QTORIN™ rapamycin, aimed at treating microcystic lymphatic malformations, a rare and serious skin disease with no existing FDA-approved therapies. The company expects to complete NDA submission in late 2026, leveraging FDA designations to …
SL Green Realty Corp., Manhattan's largest office landlord and a leading REIT, will release its financial results for the second quarter of 2026 after market close on July 22, 2026. The company will host a conference call and webcast on July 23, 2026 to discuss these results, with supplemental financial data made available concurrently on its websi…
Nuvectis Pharma has entered an exclusive licensing agreement with Haisco Pharmaceutical Group to acquire ex-China rights to two late-stage clinical compounds: NXP100, a once-daily oral Complement Factor B inhibitor targeting complement-mediated diseases including PNH, IgAN, and LN; and NXP200, a paradox-breaker BRAF inhibitor for BRAF-mutated malig…
Quantum Cyber N.V. updates shareholders on recent strategic developments including high-level engagements with U.S. government officials, a defense and military conference, progress toward acquiring a Connecticut manufacturing facility for drone production, and improved financial strength with over $15 million raised from warrant exercises, positio…
Edible Garden AG Incorporated announced that its Pickle Party™ product line was named the 2026 Mindful Award Winner for Overall Plant-Based Snack Product of the Year. The award recognizes innovation, sustainability, product quality, and mindful consumer impact. Pickle Party™ is a unique line of raw, fermented, non-GMO, clean-label pickles and kraut…
DMC Global Inc.'s NobelClad business has expanded its manufacturing capabilities in the Americas by adding weld overlay services. This new turnkey service complements NobelClad's existing clad metal solutions by enhancing corrosion resistance and wear protection for critical industrial equipment, particularly in the oil and gas, chemical processing…
GXO Logistics announced it will manage operations at a new distribution center in Ferentino, Italy, supporting Action’s expansion across Central and Southern Italy. The facility emphasizes sustainability with a BREEAM Outstanding certification and features energy-efficient technologies. This expansion strengthens GXO's partnership with Action and e…
Lithium Argentina AG held its 2026 Annual General Meeting where shareholders re-elected eight directors, approved the 2025 financial statements, approved an amended equity incentive plan, and confirmed compensation and auditor appointments. These corporate governance actions position the company for continued operation and oversight of its lithium …
Brunswick Corporation's division, Navico Group, disclosed operational changes at its Lowell, Michigan facility aimed at reducing fixed costs, improving efficiency, and supporting long-term growth. The plan includes expanding insourcing, collaborating more closely with other Brunswick divisions, and utilizing space for Land ‘N’ Sea's distribution op…
TScan Therapeutics announced positive initial results from Cohort C of its ongoing ALLOHA Phase 1 study evaluating TSC-101 in patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation. The therapy showed a high rate of complete donor chimerism shortly after infusion and was well tolerated. The company is on tra…
NRx Pharmaceuticals received FDA approval for an Expanded Access Protocol allowing compassionate use of NRX-101, a combination of D-cycloserine and lurasidone, to augment Transcranial Magnetic Stimulation (TMS) therapy in treatment-resistant depression patients. The company is concurrently conducting a pivotal clinical trial assessing NRX-101's eff…
Sparklight, a leading US broadband provider, announced the distribution of more than $125,000 in grants to 28 nonprofits as part of its Charitable Giving Fund which totals $250,000 annually. The fund supports initiatives in education and digital literacy, food insecurity, and community development across its service areas. Since 2020, Sparklight ha…
Regeneron Pharmaceuticals announced that the FDA and EMA have accepted the regulatory submissions for cemdisiran, a potential first siRNA treatment for generalized myasthenia gravis (gMG). The FDA is conducting a Priority Review with a target decision date in November 2026, and a European decision is expected in the second half of 2027. Cemdisiran …
Auddia Inc. announced engineering and deployment plans for its LT350 project, which transforms parking lots into distributed AI datacenters via a modular solar canopy platform integrating GPUs and batteries. Fresh Consulting has been engaged to lead the thermal, power, battery, and GPU integration design. This milestone progresses LT350 from concep…
MapLight Therapeutics announced topline results from the Phase 2 IRIS study evaluating ML-004 in autism spectrum disorder. While the primary endpoint related to social communication deficits was not met, a prespecified analysis revealed meaningful improvement in irritability symptoms among adolescents with moderate to severe baseline irritability. …
Traws Pharma is preparing an updated toxicology data submission to the UK MHRA for its oral antiviral candidate tivoxavir marboxil (TXM), which is planned to enter a Phase 2a influenza challenge study. The updated data package aims to address MHRA's requirements and support proof of concept for TXM as a prophylactic against seasonal influenza. The …
Eledon Pharmaceuticals released long-term data from its Phase 2 BESTOW clinical trial demonstrating that tegoprubart, an investigational anti-CD40L antibody, maintained superior kidney function compared to tacrolimus in kidney transplant recipients, with significantly higher eGFR at 18 months and no biopsy-proven acute rejection events after six mo…
Ligand Pharmaceuticals announced a proposed private placement of $550 million in convertible senior notes due 2031. The company plans to use portions of the proceeds to repurchase shares and fund convertible note hedging transactions to offset potential dilution. Remaining proceeds will support general corporate purposes, including investments and …
Seer, Inc. announced preliminary data presented at ASMS 2026 demonstrating its Proteograph Product Suite's ability to enable AI-driven approaches for large-scale, deep plasma proteomics in multi-cancer screening. Collaborating with Korea University, Seer showcased data from over 5,500 plasma samples across ten cancer types, leveraging advanced AI t…
